Key result
Current genetic and epigenetic approaches have failed to deliver expected clear-cut and reliable information for clinical decision-making in patients with myocardial infarction.
Despite extensive research, genetic and epigenetic markers for myocardial infarction are not yet reliable enough for routine clinical decision-making.
Answers are grounded in this paper and cite their sources.
Genetic/epigenetic markers should not guide MI decisions yet; leaves open need for validated, clinically actionable tools.
Myocardial Infarction (MI) is a complex multifactorial disorder caused by the interaction of environmental and genetic factors. Several types of genetic studies and approaches, such as family studies, linkage analysis, candidate gene approach, and genome wide association studies, have tried to unravel the genetic background of MI. Although it is clear that the genetic component has an important role in the development of MI, in the view of many all these approaches have failed to deliver as expected. It might be due to the fact that beside genetic factors, gene-gene interactions, and epigenetic mechanisms are most probably very much involved in the setting of MI. For clinical use, a clear cut and reliable information should be available from genetic and epigenetic studies to be of help in the decision making in patients with coronary artery disease
No takes yet. Share an insight, caveat, or question.
Stojan Kariž (2012) conducted a review in Myocardial Infarction. Genetic and epigenetic markers was evaluated. Current genetic and epigenetic approaches have failed to deliver expected clear-cut and reliable information for clinical decision-making in patients with myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: